DE69841042D1 - HP90:WIRTSREZEPTOR FüR PATHOGENE BAKTERIEN - Google Patents

HP90:WIRTSREZEPTOR FüR PATHOGENE BAKTERIEN

Info

Publication number
DE69841042D1
DE69841042D1 DE69841042T DE69841042T DE69841042D1 DE 69841042 D1 DE69841042 D1 DE 69841042D1 DE 69841042 T DE69841042 T DE 69841042T DE 69841042 T DE69841042 T DE 69841042T DE 69841042 D1 DE69841042 D1 DE 69841042D1
Authority
DE
Germany
Prior art keywords
tir
polypeptide
coli
receptors
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69841042T
Other languages
German (de)
English (en)
Inventor
Brett B Finlay
Brendan Kenny
Rebekah Devinney
Marcus Iris Stein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Application granted granted Critical
Publication of DE69841042D1 publication Critical patent/DE69841042D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69841042T 1997-11-12 1998-11-10 HP90:WIRTSREZEPTOR FüR PATHOGENE BAKTERIEN Expired - Lifetime DE69841042D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6513097P 1997-11-12 1997-11-12
PCT/CA1998/001042 WO1999024576A1 (en) 1997-11-12 1998-11-10 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene

Publications (1)

Publication Number Publication Date
DE69841042D1 true DE69841042D1 (de) 2009-09-17

Family

ID=22060539

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69841042T Expired - Lifetime DE69841042D1 (de) 1997-11-12 1998-11-10 HP90:WIRTSREZEPTOR FüR PATHOGENE BAKTERIEN

Country Status (9)

Country Link
EP (1) EP1029054B1 (https=)
JP (2) JP4410412B2 (https=)
AT (1) ATE438721T1 (https=)
AU (1) AU1137399A (https=)
CA (1) CA2309559A1 (https=)
DE (1) DE69841042D1 (https=)
ES (1) ES2333630T3 (https=)
PT (1) PT1029054E (https=)
WO (1) WO1999024576A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9901897D0 (en) * 1999-01-29 1999-03-17 Imp College Innovations Ltd Biological material and use thereof
GB0013115D0 (en) * 2000-05-31 2000-07-19 Imp College Innovations Ltd Biological materials and methods for use in the prevention or treatment of infections
NZ527322A (en) * 2001-01-04 2005-07-29 Univ Saskatchewan EHEC cell culture supernatant vaccine
CA2339436A1 (fr) 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
WO2005042746A1 (en) 2003-10-31 2005-05-12 The University Of British Columbia Bacterial virulence factors and uses thereof
WO2008133659A2 (en) 2006-11-29 2008-11-06 Tufts University Eschericia coli mutants and methods of use thereof
WO2010115278A1 (en) 2009-04-06 2010-10-14 University Of Saskatchewan Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
JP6283040B2 (ja) * 2013-03-07 2018-02-21 ザ ジェネラル ホスピタル コーポレイション 細菌によるポリペプチド送達のための組成物および方法
WO2017139366A1 (en) 2016-02-09 2017-08-17 The General Hospital Corporation D/B/A Massachusetts General Hospital Methods and compositions relating to engineered microbial cells
CN121537480B (zh) * 2026-01-16 2026-04-17 湘潭大学 一种具有多靶点降脂活性的小球藻七肽tgplgsr及其制备方法和应用

Also Published As

Publication number Publication date
PT1029054E (pt) 2009-11-11
EP1029054A1 (en) 2000-08-23
ATE438721T1 (de) 2009-08-15
JP4410412B2 (ja) 2010-02-03
ES2333630T3 (es) 2010-02-24
CA2309559A1 (en) 1999-05-20
EP1029054B1 (en) 2009-08-05
JP2001522605A (ja) 2001-11-20
AU1137399A (en) 1999-05-31
WO1999024576A1 (en) 1999-05-20
JP2009173667A (ja) 2009-08-06

Similar Documents

Publication Publication Date Title
Cunningham et al. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin.
CA2365898A1 (en) Ibd-associated microbial antigens and methods of using same
BR9710433A (pt) Proteínas associada a escherichia coli patogênica
Christmann et al. Epitope mapping and affinity purification of monospecific antibodies by Escherichia coli cell surface display of gene-derived random peptide libraries
DE69841042D1 (de) HP90:WIRTSREZEPTOR FüR PATHOGENE BAKTERIEN
WO1986004093A1 (en) Methods and compositions useful in the diagnosis and treatment of autoimmune diseases
CA2180425A1 (en) Purified primate ctla-8 antigens and related reagents
CA2328803A1 (en) Anti-procalcitonin antibodies and the preparation and use thereof
EP0896583A1 (en) Novel osp-c derived peptide fragments
US5324630A (en) Methods and compositions for diagnosing lyme disease
US6716574B2 (en) Osp-C derived peptide fragments
WO2008119358A2 (en) Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
EP0914438A1 (en) Recombinant sef14 fimbrial protein from salmonella
CA2240409A1 (en) Mammalian cx3c chemokine genes
Chaemchuen et al. Identification of candidate host proteins that interact with LipL32, the major outer membrane protein of pathogenic Leptospira, by random phage display peptide library
US5254459A (en) Nucleotide and amino acid sequences of protein MTP40 of M. tuberculosis and synthetic peptides derived therefrom
Huang et al. Host focal adhesion protein domains that bind to the translocated intimin receptor (Tir) of enteropathogenic Escherichia coli (EPEC)
DK0418590T3 (da) Antistoffer, fremstilling deraf og anvendelse deraf
DE102007025291A1 (de) Verfahren und Immunabsorbentien zur spezifischen Detektion und Absorption Zöliakie- und Dermatitis herpetiformis assoziierter Antikörper
JP2001522605A5 (https=)
CA2451347A1 (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
DE69106141T2 (de) Non-a non-b sequenzen.
CN103772509A (zh) 一种艰难梭菌毒素a/b的融合蛋白及其编码基因与应用
SE446867B (sv) Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
US7595059B2 (en) Methods and compositions for detecting larval Taenia solium with a cloned diagnostic antigen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition